Home/Pipeline/DEXTER Robotic Surgery System

DEXTER Robotic Surgery System

Adult Inguinal Hernia Repair & Cholecystectomy (General Surgery)

ApprovedCommercial

Key Facts

Indication
Adult Inguinal Hernia Repair & Cholecystectomy (General Surgery)
Phase
Approved
Status
Commercial
Company

About Distalmotion

Distalmotion is a privately held medical device company headquartered in Lausanne, Switzerland, with a mission to empower access to robotic surgery by removing operational barriers. The company's flagship product, the DEXTER Robotic Surgery System, is designed for seamless integration into existing operating room workflows, enabling more surgeons across more care sites to perform robotic procedures. Having received CE mark in 2020 and FDA clearances for specific procedures, DEXTER is now in clinical use, treating patients daily. The company employs over 150 people from more than 25 nationalities, united in bringing best-in-class minimally invasive surgical care to patients worldwide.

View full company profile

About Distalmotion

Distalmotion is a privately held medical device company headquartered in Lausanne, Switzerland, with a mission to empower access to robotic surgery by removing operational barriers. The company's flagship product, the DEXTER Robotic Surgery System, is designed for seamless integration into existing operating room workflows, enabling more surgeons across more care sites to perform robotic procedures. Having received CE mark in 2020 and FDA clearances for specific procedures, DEXTER is now in clinical use, treating patients daily. The company employs over 150 people from more than 25 nationalities, united in bringing best-in-class minimally invasive surgical care to patients worldwide.

View full company profile

About Distalmotion

Distalmotion is a privately held medical device company headquartered in Lausanne, Switzerland, with a mission to empower access to robotic surgery by removing operational barriers. The company's flagship product, the DEXTER Robotic Surgery System, is designed for seamless integration into existing operating room workflows, enabling more surgeons across more care sites to perform robotic procedures. Having received CE mark in 2020 and FDA clearances for specific procedures, DEXTER is now in clinical use, treating patients daily. The company employs over 150 people from more than 25 nationalities, united in bringing best-in-class minimally invasive surgical care to patients worldwide.

View full company profile